OIA
NVIV

OneDigital Investment Advisors’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

OneDigital Investment Advisors’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1
Closed -$14K – 1305
2017
Q3 		$14K Buy
+1
New +$30.7K 0.01% 761
2017
Q2 		– Hold
0
– – – 696

Other funds holding NVIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

OneDigital Investment Advisors's NVIV Position: Q4 2017 in Review

OneDigital Investment Advisors sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q4 2017, closing a stake of 1 share — an estimated $14K sold.

OneDigital Investment Advisors first reported a position in NVIV in Q3 2017 and held it in 1 quarter. The position peaked at $14K in Q3 2017. 28 funds tracked by Wall St. Rank hold NVIV as of Q4 2017.

  • OneDigital Investment Advisors reported no remaining InVivo Therapeutics Holdings Corp position as of Q4 2017 after selling out during the quarter.
  • OneDigital Investment Advisors sold 1 InVivo Therapeutics Holdings Corp share in Q4 2017, an estimated $14K.
  • OneDigital Investment Advisors first reported a position in InVivo Therapeutics Holdings Corp in Q3 2017 and held it in 1 quarter.
  • OneDigital Investment Advisors's InVivo Therapeutics Holdings Corp position peaked at $14K in Q3 2017.
  • 28 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2017.

Based on OneDigital Investment Advisors's 13F filing for Q4 2017, filed 31 Jan 2018.